Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
Introduction: Numerous real-world studies have compared non-vitamin K antagonist oral anticoagulants (NOACs) with vitamin K antagonists (VKAs) in patients with non-valvular atrial fibrillation (NVAF). A meta-analysis was performed to synthesize the available evidence. Methods: Systematic searches we...
Saved in:
Main Authors: | Craig I. Coleman (Author), Jean-Baptiste Briere (Author), Laurent Fauchier (Author), Pierre Levy (Author), Kevin Bowrin (Author), Mondher Toumi (Author), Aurélie Millier (Author), Vanessa Taieb (Author), Olivia Wu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective
by: Pierre Levy, et al.
Published: (2019) -
Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK
by: Kevin Bowrin, et al.
Published: (2020) -
Non-Vitamin K Antagonist Oral Anticoagulants A Concise Guide
by: Shantsila, Eduard
Published: (2016) -
Non-Vitamin K Antagonist Oral Anticoagulants A Concise Guide /
by: Shantsila, Eduard, et al.
Published: (2016) -
Non-Vitamin K Antagonist Oral Anticoagulants A Concise Guide
by: Shantsila, Eduard
Published: (2016)